A detailed history of Headlands Technologies LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Headlands Technologies LLC holds 699 shares of ASND stock, worth $91,464. This represents 0.01% of its overall portfolio holdings.

Number of Shares
699
Previous 6,338 88.97%
Holding current value
$91,464
Previous $864,000 87.96%
% of portfolio
0.01%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.0 - $153.43 $637,207 - $865,191
-5,639 Reduced 88.97%
699 $104,000
Q2 2024

Aug 07, 2024

BUY
$121.07 - $153.67 $767,341 - $973,960
6,338 New
6,338 $864,000
Q4 2023

Feb 02, 2024

BUY
$86.1 - $127.36 $10,418 - $15,410
121 New
121 $15,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.3B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.